Lynch Syndrome Panel
Definition
Lynch syndrome is a cancer predisposition syndrome caused by hereditary variants in the DNA mismatch repair (MMR) genes; this panel includes MLH1, MSH2, MSH6, PMS2, and EPCAM, in addition to PMS1 and MLH3. MLH1 variants account for approximately 40% of Lynch syndrome cases. Loss of function leads to microsatellite instability; colorectal and endometrial cancer are the most common, and cancers generally appear at an early age. The evidence for the role of PMS1 and MLH3 in the disease is weaker than for the five main genes (MLH1/MSH2/MSH6/PMS2/EPCAM); this distinction should be taken into account when interpreting results.
Gene/region examined
MLH1, MSH2, PMS2, EPCAM, PMS1, MLH3, MSH6
Method
Next-Generation Sequencing, CNV Analysis
Accepted sample types
EDTA Blood
Description
7 gene regions associated with Lynch Syndrome are analyzed.
Inheritance
Autosomal dominant, a pathogenic variant in one copy of the gene is sufficient, and the probability of transmission is 50% in each pregnancy.